Have a personal or library account? Click to login

Granulocyte serology: current concepts and clinical signifcance

Paid access
|Mar 2020

References

  1. Lalezari P, Nussbaum M, Gelman, et al. Neonatal neutropenia due to maternal isoimmunization. Blood 1960;15:236–43.10.1182/blood.V15.2.236.236
  2. Bux J, Jung KD, Kauth T, et al. Serological and clinical aspects of granulocyte antibodies leading to alloimmune neonatal neutropenia. Transfus Med 1992;2:143–9.10.1111/j.1365-3148.1992.tb00148.x
  3. Rodwell RL, Gray PH, Taylor KM, et al. Granulocyte colony stimulating factor treatment for alloimmune neonatal neutropenia. Arch Dis Child Fetal Neonatal Ed 1996;75:F57-8.10.1136/fn.75.1.F57
  4. Rodney GE, Lalezari P. HLA and neutrophil antigen and antibody systems. In: Hoffman R, Benz E, Shattil SJ, eds. Hematology basic principles and practice. 3rd ed. New York: Churchill Livingstone, 2000:2220–41.
  5. Lalezari P. Alloimmune neonatal neutropenia. In: Engelfriet CP,Van Logham JJ, von dem Borne AEGKr, eds. Immunohaematology. Amsterdam: Elsevier Science Publishers, 1984:179–86.
  6. Clay M, Kline W, McCullough J. Serological examination of postpartum sera for the presence of neutrophil-specific antibodies (abstract). Transfusion 1981;21:616.
  7. Levine DH, Madyastha P, Wade R, Levkoff AH. Neonatal isoimmune neutropenia (abstract). Pediatr Res 1981;15:296A.
  8. Lalezari P, Bernard GE. An isologous antigen-antibody reaction with human neutrophils, related to neonatal neutropenia. J Clin Invest 1966;45:1741–50.10.1172/JCI105480
  9. Verheugt FWA, van Noord-Bokhorst JC, von dem Borne AEGKr, et al. A family with alloimmune neonatal neutropenia: group specific pathogenicity of maternal antibodies. Vox Sang 1979;36:1–8.10.1111/j.1423-0410.1979.tb04390.x
  10. van der Weerdt CM, Lalezari P. Another example of isoimmune neonatal neutropenia due to anti-NA1. Vox Sang 1972;22:438–46.10.1159/000464541
  11. Boxer LA, Yokoyama M, Lalezari P. Isoimmune neonatal neutropenia. J Pediatr 1972;80:783–7.10.1016/S0022-3476(72)80131-8
  12. Bux J, Ernst-Ludwig Stein, Bierling P, et al. Characterization of a new alloantigen (SH) on the human neutrophil Fc gamma receptor IIIb. Blood 1997;89:1027–34.10.1182/blood.V89.3.1027
  13. Schuller RM, Stroncek DF, Alpan O, et al. Different responses observed between G-CSF and GM-CSF therapy in a case of neonatal alloimmune neutropenia (abstract). Transfusion 2008;48(Suppl):53A.
  14. Bachowski GJ, Mair DC, Schuller RM, et al. Alloimmune neonatal neutropenia in monozygous twins caused by antibody to FcyRIIIb in a mother lacking CD16 antigen (abstract). Transfusion 2007;47(Suppl):21A.
  15. Stroncek DF, Sharpiro RS, Filipovich AH, et al. Prolonged neutropenia resulting from antibodies to neutrophil-specific antigen NB1 following marrow transplantation. Transfusion 1993;33:158–63.10.1046/j.1537-2995.1993.33293158050.x8430456
  16. de Haas M, Muniz-Diaz E, Alonso LG, et al. Neutrophil antigen 5b is carried by a protein, migrating from 70 to 95 kDa, and may be involved in neonatal alloimmune neutropenia. Transfusion 2000;40:222–7.10.1046/j.1537-2995.2000.40020222.x10686007
  17. Fung L, Pitcher LA, Willett JE, et al. Alloimmune neonatal neutropenia linked to anti-HNA-4a. Transfus Med 2003;13:49–52.10.1046/j.1365-3148.2003.00413.x
  18. Bux J, Behrens G, Jaeger G, et al. Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases. Blood 1998;91:181–6.10.1182/blood.V91.1.181
  19. Bux J, Kissel K, Nowak K, et al. Autoimmune neutropenia: clinical and laboratory studies in 143 patients. Ann Hematol 1991;63:249–52.10.1007/BF01698373
  20. Stroncek D. Granulocyte antigens and antibody detection. Vox Sang 2004;87(Suppl 1):91–4.10.1111/j.1741-6892.2004.00439.x
  21. Sperner-Unterweger B, Czeipek I, Gaggl S, Geissler D, Spiel G, Fleischhacker WW. Treatment of severe clozapine-induced neutropenia with granulocyte colony stimulating factor (G-CSF). Remission despite continuous treatment with clozapine. Br J Psychiatry 1998;172:82–4.10.1192/bjp.172.1.82
  22. Stroncek DF. Drug-induced immune neutropenia. Transfus Med Rev 1993;7:268–74.10.1016/S0887-7963(93)70146-7
  23. Mamus SW, Burton JD, Groat JD, et al. Ibuprofen-associated pure white cell aplasia. N Engl J Med 1986;314:624–5.10.1056/NEJM1986030631410063945248
  24. Holness L, Knippen MA, Simmons L, et al. Fatalities caused by TRALI. Transfus Med Rev 2004;18:184–8.10.1016/j.tmrv.2004.03.00415248168
  25. Brittingham TE. Immunologic studies on leukocytes. Vox Sang 1952;2:242–8.10.1111/j.1423-0410.1957.tb03699.x13496693
  26. Barnard, RD. Indiscriminate transfusion: a critique of case reports illustrating hypersensitivity reactions. N Y State J Med 1951;51:2399–402.
  27. Popovsky MA, Moore SB. Diagnostic and pathogenic considerations in transfusion-related acute lung injury. Transfusion 1985;25:573–7.10.1046/j.1537-2995.1985.25686071434.x4071603
  28. Bux J, Sachs UJ. The pathogenesis of transfusion-related acute lung injury (TRALI). Br J Haematol 2007;136:788–99.10.1111/j.1365-2141.2007.06492.x17341264
  29. Reil A, Keller-Stanislawski B, Gunay S, et al. Specificities of leukocyte alloantibodies in transfusion-related acute lung injury and results of leukocyte antibody screening of blood donors. Vox Sang 2008;95:313–17.10.1111/j.1423-0410.2008.01092.x19138261
  30. Ward HN. Pulmonary infiltrates associated with leukoagglutinin transfusion reactions. Ann Intern Med 1970;73:689–94.10.7326/0003-4819-73-5-6895312202
  31. Thompson JS, Severson CD, Parmely MJ, et al. Pulmonary ‘hypersensitivity’ reactions induced by transfusion of non-HLA lekoagglutinins. N Engl J Med 1971;284:1120–5.10.1056/NEJM1971052028420035553486
  32. Nordhagen R, Conradi M, Drotorp SM. Pulmonary reaction associated with transfusion of plasma containing anti-5b. Vox Sang 1986;51:102–7.10.1111/j.1423-0410.1986.tb00223.x3095987
  33. Kopko PM, Marshall CS, MacKenzie MR, et al. Transfusion-related acute lung injury. Report of a clinical look-back investigation. JAMA 2002;287:1968–71.10.1001/jama.287.15.196811960539
  34. Davoren A, Curtis BR, Shulman IA, et al. TRALI due to granulocyte-agglutinating human neutrophil antigen3a (5b) alloantibodies in donor plasma: a report of 2 fatalities. Transfusion 2003;43:641–5.10.1046/j.1537-2995.2003.00374.x12702187
  35. Silliman CC, Curtis BR, Kopko PM, et al. Donor antibodies to HNA-3a implicated in TRALI reactions prime neutrophils and cause PMN-mediated damage to human pulmonary microvascular endothelial cells in a two-event in vitro model. Blood 2007;109:1752–5.10.1182/blood-2006-05-025106179405517038531
  36. Sachs UJ, Chavakis T, Fung L, et al. Human alloantibody anti-MART interferes with Mac-1-dependent leukocyte adhesion. Blood 2004;104:727–34.10.1182/blood-2003-11-380915073035
  37. Kopko PM, Curtis BR, Kelher M, et al. Merging the pathogenesis of transfusion-related acute lung injury: the priming activity of the 5b (HNA-3) antibody (abstract). Transfusion 2004;44(Suppl 1):22A.
  38. Sachs UJ, Hattar K, Weissman N, et al. Antibody-induced neutrophil activation as a trigger for transfusion-related acute lung injury in an ex vivo rat lung model. Blood 2006;107:1217–9.10.1182/blood-2005-04-174416210340
  39. Fung YL, Silliman CS. The role of neutrophils in the pathogenesis of transfusion-related acute lung injury. Transfusion Med Rev 2009;23:266–83.10.1016/j.tmrv.2009.06.001293722119765516
  40. Lalezari P, Radel E. Neutrophil-specific antigens: immunology and clinical significance. Semin Hematol 1974;11:281–90.
  41. Lalezari P, Murphy GB, Allen FH. NB1, a new neutrophil antigen involved in the pathogenesis of neonatal neutropenia. J Clin Invest 1971;50:1108–15.10.1172/JCI1065822920335552408
  42. Huang ST, Lin J, McGowan El, et al. NB2, a new allele of NB1 antigen involved in febrile transfusion reaction (abstract). Transfusion 1982;22:426.
  43. Lalezari P, Petrosova M, Jiang AF. NB2, an allele of NB1 neutrophil specific antigen: relationship to 9a (abstract). Transfusion 1982;22:433.
  44. Lalezari P, Thelenfeld B, Weinstein WJ. The third neutrophil antigen. In: Terasaki PI, ed. Histocompatibility testing. Baltimore: Williams & Wilkins, 1970:319–22.
  45. Verheugt FWA, von dem Borne AEGKr, van Noord-Bokhorst JC, et al. ND1, a new neutrophil granulocyte antigen. Vox Sang 1978;35:13–17.
  46. Claas FHJ, Langerak J, Sabbe LJM, et al. NE1, a new neutrophil specific antigen. Tissue Antigens 1979;13:129–34.10.1111/j.1399-0039.1979.tb01148.x87023
  47. Thompson JS, Overlin VL, Herbick JM, et al. New granulocyte antigens demonstrated by microgranulocytotoxicity assay. J Clin Invest 1980;65:1431–9.10.1172/JCI1098073714816157700
  48. Hasegawa T, Bergh OJ, Mickay MR, et al. Preliminary human granulocyte specificities. Transplant Pro 1975;7(Suppl 1):75–80.
  49. Caplan SN, Berkman EM, Babior BM. Cytotoxins against a granulocyte antigen system: detection by a new method employing cytochalasin-B-treated cells. Vox Sang 1977;33:206–11.10.1111/j.1423-0410.1977.tb04465.x898839
  50. Van Leeuwen A, Eerrise JG, van Room JJ. A new leukocyte group with two alleles: leukocyte group five. Vox Sang 1964;9:431–7.10.1159/000464883
  51. Van Rood JJ, van Leeuwen A, Schippers AMJ, et al. Immunogenetics of the group four, five and nine systems. In: Curton ES, Mattiuz PI, Tosi RM, eds. Histocompatibility testing. Baltimore: Williams & Wilkins, 1967:203–19.
  52. Kline WE, Press C, Clay M, et al. Three sera defining a new granulocyte-monocyte-T lymphocyte antigen. Vox Sang 1986;50:181–6.
  53. Madyastha PR, Glassman A, Levine D, et al. Identification of a new neutrophil antigen (CN1) more prevalent among American blacks (abstract). Transfusion 1983;23:426.
  54. Schnell M, Halligan G, Herman J. A new granulocyte antibody directed at a high frequency antigen causing neonatal alloimmune neutropenia (abstract). Transfusion 1989;29(Suppl):46S.
  55. Rodwell RL, Tudehope DI, O’Regan P, et al. Alloimmune neonatal neutropenia in Australian aboriginals: an unrecognized disorder? Transfusion Med 1991;1:63–7.10.1111/j.1365-3148.1991.tb00011.x9259829
  56. Stroncek DF, Ramsey G, Herr GP, et al. Identification of a new white cell antigen. Transfusion 1994;34:706–11.10.1046/j.1537-2995.1994.34894353468.x8073489
  57. Bux J, Bierling P, von dem Borne AE, et al. ISBT Granulocyte Antigen Working Party. Nomenclature of granulocyte alloantigens. (letter).Vox Sang 1999;77:251.
  58. Bux J. Human neutrophil alloantigens. Vox Sang 2008;94:277–85.10.1111/j.1423-0410.2007.01031.x18208407
  59. Greinacher A, Wesche J, Hammer E, et al. Characterization of the human neutrophil alloantigen-3a. Nature Med 2010;16:45–8.10.1038/nm.207020037594
  60. Curtis BR, Cox NJ, Sullivan MJ, et al. The neutrophil alloantigen HNA-3a (5b) is located on choline transporter-like protein 2 (CTL2) and appears to be encoded by an R>Q 154 amino acid substitution. Blood 2010;115:2073–6.10.1182/blood-2009-11-248336283733220040764
  61. Shows TB, McAlpine PJ, Boucheix C, et al. Guidelines for human gene nomenclature. An international system for human gene nomenclature (ISGN, 1987). Cytogenet Cell Genet 1987;46:11–28.
  62. Stroncek DF, Skubitz KM, Plachta LB, et al. Alloimmune neonatal neutropenia due to an antibody to the neutrophil Fc-gamma receptor III with maternal deficiency of CD16 antigen. Blood 1991;77:1572–80.10.1182/blood.V77.7.1572.1572
  63. Stroncek DF, Skubitz K, McCullough JJ. Biochemical nature of the neutrophil-specific antigen NB1. Blood 1990;75:744–55.10.1182/blood.V75.3.744.744
  64. Matsuo K, Lin A, Procter JL, et al. Variations in the expression of granulocyte antigen NB1. Transfusion 2000;40:654–62.10.1046/j.1537-2995.2000.40060654.x10864984
  65. Bux J, Jung KD, Kauth T, et al. Serological and clinical aspects of granulocyte antibodies leading to alloimmune neonatal neutropenia. Transfusion Med 1992;2:143–9.10.1111/j.1365-3148.1992.tb00148.x1284978
  66. Bux J. Granulocyte antibody mediated neutropenias and transfusion reactions. Infusions Ther Transfusion Med 1999;26:152–7.10.1159/000053481
  67. Bux J, Becker F, Seeger W, et al. Transfusion-related acute lung injury due to HLR-A2-specific antibodies in recipient and NB1-specific antibodies in donor blood. Br J Haematol 1996;93:707–13.10.1046/j.1365-2141.1996.d01-1703.x8652399
  68. Stroncek DF, Shankar RH, Herr GP. Quinine-dependent antibodies to neutrophils react with a 60 kD glycoprotein on which neutrophil-specific antigen NB1 is located and an 85 kD glycosylphosphatidylinositol-linked N-glycosylated plasma membrane protein. Blood 1993;81:2758–66.10.1182/blood.V81.10.2758.2758
  69. Lalezari P, Bernard GE. Identification of a specific leukocyte antigen: another presumed example of 5b. Transfusion 1965;5:132–42.10.1111/j.1537-2995.1965.tb01148.x14269951
  70. de Haas M, Muniz-Diaz E, Alonso LG, et al. Neutrophil 5b is carried by a protein, migrating from 70 to 95 kDa, and may be involved in neonatal alloimmune neutropenia. Transfusion 2000;40:222–7.10.1046/j.1537-2995.2000.40020222.x10686007
  71. Simsek S, van der Schoot CE, Daams M, et al. Molecular characterization of antigenic polymorphisms (ONDa and MARTa) of the ß2 family recognized by human leukocyte alloantisera. Blood 1996;88:1350–8.10.1182/blood.V88.4.1350.bloodjournal8841350
  72. Fung L, Pitcher LA, Willett JE, et al. Alloimmune neonatal neutropenia linked to anti-HNA-4a. Transfusion Med 2003;13:49–52.10.1046/j.1365-3148.2003.00413.x
  73. Hartman KR, Wright DG. Identification of autoantibodies specific for the neutrophil adhesion glycoproteins CD11b/CD18 in patients with autoimmune neutropenia. Blood 1991;78:1096–104.10.1182/blood.V78.4.1096.1096
  74. Kelton JG, Bebenek G. Granulocytes do not have surface ABO antigens. Transfusion 1985;25:567–9.10.1046/j.1537-2995.1985.25686071432.x
  75. Dunstan RA, Simpson MB, Sanfilippo FP. Absence of specific HLA-DR antigens on human platelets and neutrophils (abstract). Blood 1984;64:85a.
  76. Thorsby E. HLA antigens on human granulocytes studied with cytotoxic iso-antisera obtained by skin grafting. Scan J Haematol 1969;6:119–27.10.1111/j.1600-0609.1969.tb01813.x
  77. Sachs UJ,Bux J.TRALIafter transfusion ofcross-match-positive granulocytes. Transfusion 2003;43:1683–6.
  78. Stroncek DF, Leonard K, Eiber G, et al. Alloimmunization after granulocyte transfusions. Transfusion 1996;36:1009–15.10.1046/j.1537-2995.1996.36111297091747.x
  79. McCullough J, Clay M, Hurd D, et al. Effect of leukocyte antibodies and HLA matching on the intravascular recovery, survival, and tissue localization of 111-indium granulocytes. Blood 1986;67:522–8.10.1182/blood.V67.2.522.522
  80. Bøyum A. Isolation of mononuclear cells and granulocytes from blood. Isolation of mononuclear cells by one centrifugation and of granulocytes by combining centrifugation and sedimentation at 1g. Scan J Clin Lab Invest 1968;21(Suppl 97)177-89.
  81. English D, Anderson BR. Single-strep separation of red blood cells, granulocytes, and mononuclear leukocytes on discontinuous density gradients of Ficoll-Hypaque. J Immunol Methods 1975;5:249–52.10.1016/0022-1759(74)90109-4
  82. Ferrante A, Thong YH. A rapid one-step procedure for purification of mononuclear and polymorphonuclear leukocytes from human blood using a modification of the Hypaque-Ficoll technique. J Immunol Methods 1978;24:389–93.10.1016/0022-1759(78)90143-6
  83. Ferrante A, Thong HY. Optimal conditions for simultaneous purification of mononuclear and polymorphonuclear leukocytes from human blood by the Hypaque-Ficoll method. J Immunol Methods 1980;36:109–17.10.1016/0022-1759(80)90036-8
  84. Madyastha P, Madyastha KR, Wade T, et al. An improved method for rapid layering of Ficoll-Hypaque double density gradients suitable for granulocyte separation. J Immunol Methods 1982;42:281–6.10.1016/0022-1759(82)90328-3
  85. Lucas G, Rogers S, de Haas M, et al. Report on the Fourth International Granulocyte Immunology Workshop: progress toward quality assessment. Transfusion 2002;42:462–8.10.1046/j.1525-1438.2002.00053.x
  86. Lalezari P, Pryce S. Detection of neutrophil and platelet antibodies in immunologically induced neutropenia and thrombocytopenia. In: Rose NR, Friedman H, eds. Manual of clinical immunology. Washington, DC: American Society of Microbiology 1980;744-9.
  87. McCullough J, Clay ME, Press C, et al. Granulocyte serology: a clinical and laboratory guide. Chicago: ASCP Press, 1988:12–14, 168-71.
  88. Verheugt FWA, Von dern Borne AEGKr, Decary S, et al. The detection of granulocyte alloantibodies with an indirect immunofluorescence test. Br J Haematol 1977;36:533–44.10.1111/j.1365-2141.1977.tb00994.x
  89. Kiefel V, Santoso S, Weisheit M, et al. Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet reactive antibodies. Blood 1987;70:1722–6.10.1182/blood.V70.6.1722.1722
  90. Minchinton R, Noonan K, Johnson TJ. Examining technical aspects of the monoclonal antibody immobilization of granulocyte antigen assay. Vox Sang 1997;73:87–92.10.1159/000461912
  91. Stroncek D. Neutrophil alloantigens. Transfusion Med Rev 2002;16:67–75.10.1053/tmrv.2002.29406
  92. Wang E, Marincola FM, Stroncek D. Human leukocyte antigens and human neutrophil antigens systems. In: Hoffman R, Benz E, Shattil Sj, et al., eds. Hematology: basic principel and practices 4th ed. Philadelphia: Elsevier, 2005:2401–22.
  93. Kissel K, Scheffler S, Kerowgan M, et al. Molecular basis of NB1 (HNA-2a, CD177) deficiency. Blood 2002;99:4231–3.10.1182/blood.V99.11.4231
  94. Vigrali DA. Multiplexed particle-based flow cytometric assays. J Immunol Methods 2000;243:243–55·10.1016/S0022-1759(00)00238-6
  95. Stroncek DF, Adams S, Lee JH, et al. Neutrophil antibody testing. ASHI Q 2008;32:68–72.
  96. Bux J, Kissel K, Hofmann C, et al. The use of allele-specific recombinant Fcy receptor IIIb antigens for the detection of granulocyte antibodies. Blood 1999;93:357–62.10.1182/blood.V93.1.357
  97. Yasui K, Miyazaki T, Matsuyama N, et al. Establishment of cell lines stably expressing HNA-1a, 1b, and -2a antigen with low background reactivity in flow cytometric analysis. Transfusion 2007;47:478–86.10.1111/j.1537-2995.2006.01139.x17319829
  98. Yasui K, Hirayama F, Matsuyama N, et al. New cell lines express HNA-1c, -4a, -4b, -5a, or -5b for identification of HNA antibodies. Transfusion 2008;48:1037–9.10.1111/j.1537-2995.2008.01705.x18454741
  99. Lucas GF, Carrington PA. Results of the First International Granulocyte Serology Workshop. Vox Sang 1990;59:251–6.10.1111/j.1423-0410.1990.tb00249.x1981408
  100. Bux J, Chapman J. Report on the Second International Granulocyte Serology Workshop. Transfusion 1997;37:977–83.10.1046/j.1537-2995.1997.37997454028.x9308648
  101. ISBT Working Party on Granulocyte Immunobiology. Recommendations of the ISBT Working Party on Granulocyte Immunobiology for leukocyte antibody screening in the investigation and prevention of antibody-mediated transfusion-related acute lung injury. Vox Sang 2009;96:266–7.10.1111/j.1423-0410.2008.01144.x19207164
DOI: https://doi.org/10.21307/immunohematology-2019-195 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 11 - 21
Published on: Mar 12, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year

© 2020 M.E. Clay, R.M. Schuller, G.J. Bachowski, published by American National Red Cross
This work is licensed under the Creative Commons License.